Skip to main content
OpenTrials

Clinical trial condition

Transthyretin (TTR)-Mediated Amyloidosis

Explore clinical trials studying Transthyretin (TTR)-Mediated Amyloidosis. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Transthyretin (TTR)-Mediated Amyloidosis trial results

Completed

The Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Whose Disease Has Continued to Worsen Following Liver Transplant

NCT02595983

Conditions
ATTR Amyloidosis, Amyloid Neuropathies, Amyloid Neuropathies, Familial, +16 more
Locations
  • Clinical Trial SIte Paris, France
  • Clinical Trial SIte Münster, Germany
  • Clinical Trial SIte Porto, Portugal
  • Clinical Trial SIte Majorca, Spain
View Trial Details

Related conditions